ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression

Metastatic cancer is extremely difficult to treat, and the presence of metastases greatly reduces a cancer patient’s likelihood of long-term survival. The ZEB1 transcriptional repressor promotes metastasis through downregulation of microRNAs (miRs) that are strong inducers of epithelial differentiat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ahn, Young-Ho, Gibbons, Don L., Chakravarti, Deepavali, Creighton, Chad J., Rizvi, Zain H., Adams, Henry P., Pertsemlidis, Alexander, Gregory, Philip A., Wright, Josephine A., Goodall, Gregory J., Flores, Elsa R., Kurie, Jonathan M.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3428095/
https://ncbi.nlm.nih.gov/pubmed/22850877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI63608
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars